Transgender cancer patients may not realize treatment can interact with their hormone therapy

Reuters Health - 19/11/2020 - Transgender cancer patients often were not told of potential interactions between cancer treatment and gender-affirming hormone therapy, a case series reveals. "We found few patients had documentation of conversations regarding how cancer care may affect their prior, ongoing, or future gender-affirming care," Dr. Daphne Haas-Kogan of Brigham and Women's Hospital in Boston told Reuters Health by email. "In addition, many patients transition after their cancer care, which means oncology providers need to revisit these topics during survivorship care." When there was documentation, cancer practitioners rarely used pronouns used by patients, she noted. "Correct pronoun use is essential in affording dignity and respect to our gender-diverse patients whether during conversations or when documenting patient encounters in the medical record." For the JAMA Oncology report, Dr. Haas-Kogan and colleagues assessed 37 transgender cancer patie...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 19 November, 202026 November, 2020